FRTX-02

N/A

Report date: 2022/09/21 17:00:30

Base Information

Drug NameFRTX-02
Drug Alias NameBBI-02VRN-02FRTX-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsPsoriasisEczemaDermatitis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVoronoi Inc
China Registration ClassN/A

Develop Information

Active CompaniesVoronoi IncFresh Tracks Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitisLupus Erythematosus, Systemic +[6] 
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A